OVERVIEW
Primary biliary cholangitis (PBC) is a chronic, progressive autoimmune disease of the liver, which, if undertreated, can progress to cirrhosis, liver failure, and death. FDA-approved treatment options for PBC are presently limited, and many patients do not have an adequate response to first- and second-line therapies and/or experience adverse effects that limit their use and impair patients’ quality of life. A new generation of PBC therapies with novel mechanisms of action are in late-stage development. In this live, interactive, case-based symposium, expert faculty will review the latest information on the diagnosis and management of PBC and will delve into clinical evidence for emerging therapies. Patient cases will provide clinical context and useful pointers for clinical decision-making in PBC management.
GOAL STATEMENT
The goal of this activity is for learners to be better able to diagnose and manage PBC and improve their understanding of emerging treatments with novel mechanisms of action.
LEARNING OBJECTIVES
Upon completion of this activity, participants will: Have increased knowledge regarding the[LIST][ITEM]Impact and burden of PBC on patients’ quality of life[ITEM]Data on emerging targeted PBC treatments[/LIST]Have greater competence related to [LIST][ITEM]Diagnosing PBC in accordance with evidence-based criteria [/LIST]Demonstrate greater confidence in their ability to[LIST][ITEM]Implement PBC treatments that address patients’ symptoms
ACCREDITATION STATEMENT
In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [JALOGO] [MEDSCAPE]
[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 1.5 [italic][bold]AMA PRA Category 1 Credit(s)™[/bold][/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hynes Convention Center
Room: 210
900 Boylston Street
Boston, MA 02115
Presented for attendees of The Liver Meeting® 2023. This event/function is provided by Medscape Education and supported by CymaBay Therapeutics. This is not an official event/function of the American Association for the Study of Liver Diseases.
Supported by an independent educational grant from [bold]CymaBay Therapeutics[/bold].